Sapphire Star Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sapphire Star Partners's AMGN Position: Q4 2018 in Review
Sapphire Star Partners reduced its Amgen (AMGN) stake by 3.2% in Q4 2018, selling an estimated $114K and leaving 17,840 shares worth $3.47M. The position accounts for 4.65% of the portfolio, ranked #2.
Sapphire Star Partners first reported a position in AMGN in Q4 2015 and has held it in 13 quarters since. The position peaked at $7.66M in Q3 2016. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.
- Sapphire Star Partners held 17,840 shares of Amgen worth $3.47M as of Q4 2018.
- Sapphire Star Partners sold 586 Amgen shares in Q4 2018, an estimated $114K.
- Amgen made up 4.65% of Sapphire Star Partners's portfolio in Q4 2018, its #2 holding.
- Sapphire Star Partners first reported a position in Amgen in Q4 2015 and has held it in 13 quarters since.
- Sapphire Star Partners's Amgen position peaked at $7.66M in Q3 2016.
- 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.
Based on Sapphire Star Partners's 13F filing for Q4 2018, filed 12 Feb 2019.